Doomsday AMR scenarios lurk: What's FDA, others doing?
This article was originally published in Scrip
Executive Summary
With antimicrobial-resistance (AMR) doomsday scenarios coming fast and furious in recent months – with one even projecting as many as 10 million people worldwide could be sickened by "superbug" infections by 2050 – one wonders why with all the dire warnings the problem has not yet been solved and why it's been such a tough nut to crack.